Abstract:To investigate the prevalence and the mechanism of quinolone-resistant Acinetobacter pittii, 634 Acinetobacter calcoaceticus-Acinetobacter baumannii complex isolates were collected throughout Zhejiang Province. Identification of isolates was conducted by matrix-assisted laser desorption ionization/time of flight mass spectrometry (MALDI-TOF MS), bla(OXA-51)-like gene, and partial RNA polymerase -subunit (rpoB) amplification. Twenty-seven isolates of A. pittii were identified. Among the 634 isolates, A. baumannii, A. pittii, Acinetobacter nosocomialis, and A. calcoaceticus counted for 87.22%, 4.26%, 8.20%, and 0.32%, respectively. Antimicrobial susceptibility of nalidixic acid, ofloxacin, enoxacin, ciprofloxacin, lomefloxacin, levofloxacin, sparfloxacin, moxifloxacin, and gatifloxacin for 27 A. pittii were determined by the agar dilution method. Detection of quinolone-resistant determining regions of gyrA, gyrB, parC, and parE was performed for the A. pittii isolates. In addition, plasmid-mediated quinolone resistance (PMQR) determinants (qnrA, qnrB, qnrS, qnrC, qnrD, aac(6)-Ib-cr, qepA, oqxA, and oqxB) were investigated. All the 27 isolates demonstrated a higher minimum inhibitory concentration (MIC) to old quinolones than the new fluoroquinolones. No mutation in gyrA, gyrB, parC, or parE was detected in 20 ciprofloxacin-susceptible isolates. Seven ciprofloxacin-resistant A. pittii were identified with a Ser83Leu mutation in GyrA. Among them, six isolates with simultaneous Ser83Leu amino acid substitution in GyrA and Ser80Leu in ParC displayed higher MIC values against ciprofloxacin. Additionally, three were identified with a Met370Ile substitution in ParE, and two were detected with a Tyr317His mutation in ParE, which were reported for the first time. No PMQR determinants were identified in the 27 A. pittii isolates. In conclusion, mutations in chromosome play a major role in quinolone resistance in A. pittii, while resistance mechanisms mediated by plasmid have not been found. Ser83Leu substitution in GyrA and Ser80Leu substitution in ParC are associated with quinolone resistance in A. pittii. Whether Met370Ile and Tyr317His substitutions in ParE play a minor role requires further investigation.

Mutational alterations in the QRDR regions associated with fluoroquinolone resistance in of clinical origin from Savar, Dhaka

Analysis of quinolone-resistance genes in Klebsiella pneumoniae JM45 by whole genome sequencing

Emergence of Novel Variants of Gyra, Parc, Qnrs Genes in Multi-Drug Resistant Klebsiella Caused Pneumonia

Study on the resistance-related genes of Shigella sonnei with decreased susceptibility to fluoroquinolones

On the Resistance of Escherichia Coli Strains Isolated from Healthy People's Intestines to Fluroquinolones and Its Mechanism

Substitutions of Ser83Leu in GyrA and Ser80Leu in ParC Associated with Quinolone Resistance Inacinetobacter Pittii

Trends in the rates of resistance of Ureaplasma urealyticum to antibiotics and identification of the mutation site in the quinolone resistance-determining region in Chinese patients.

Molecular basis of quinolone resistance in clinical isolates of Klebsiella pneumoniae from Pakistan

Genetic and in-silico approaches for investigating the mechanisms of ciprofloxacin resistance in Salmonella typhi: Mutations, extrusion, and antimicrobial resistance

Transferable Quinolone Resistance in Vibrio Cholerae.

A study on GyrA and ParC mutant in fluoroquinolone-resistant clinical isolates of Klebsiella pneumoniae

Investigation of mutation distribution in DNA gyrase and topoisomerase IV genes in ciprofloxacin-non-susceptible Enterobacteriaceae isolated from blood cultures in a tertiary care university hospital in South Korea, 2005–2010

Association of gyrA/B mutations and resistance levels to fluoroquinolones in clinical isolates of Mycobacterium tuberculosis

Amino acid 17 in QRDR of Gyrase A plays a key role in fluoroquinolones susceptibility in mycobacteria

[Molecular mechanisms of quinolone resistance in non-typhoidal Salmonella]

Mutations in the Gyra and Parc Genes of Quinolone-Resistant Shigella Flexneri Clinical Isolates

Plasmid-mediated Quinolone Resistance in Clinical Isolates of Gram-Negative Bacilli

Frequent topoisomerase IV mutations associated with fluoroquinolone resistance in Ureaplasma species

A Study on the Correlation of Quinolone Resistance with Mutations in DNA Gyrase Gyra and Topoisomerase IV Parc Genes in Salmonella Typhi

Navigating fluoroquinolone resistance in Gram-negative bacteria: a comprehensive evaluation

Molecular epidemiology and genetic diversity of fluoroquinolone-resistant Escherichia coli isolates from patients with community-onset infections in 30 Chinese county hospitals